Abiopharma

🔍 DONNELLY WILLIAM P (Executive)

Company: Quanterix Corp (QTRX)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 27,155 shares of Common Stock at $2.75 per share (Direct)
  Date: 2026-08-12 | Code: P | equity_swap_involved: false | shares_owned_after: 27,155.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 72,245 shares of Common Stock at $2.93 per share (Direct)
  Date: 2026-08-13 | Code: P | equity_swap_involved: false | shares_owned_after: 99,400.00 | transaction_form_type: 4 | Footnotes: F3, F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.58 to $2.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F2: Owned jointly by trusts established by the reporting person and his spouse.
• F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.85 to $3.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.